Evidence map›Paper›PMID 23947319›Full record

Trial reportAmerican journal of public health2013

A randomized trial of a hepatitis care coordination model in methadone maintenance treatment.

Carmen L Masson, Kevin L Delucchi, Courtney McKnight, Jennifer Hettema, Mandana Khalili, Albert Min, Ashly E Jordan, Nicole Pepper, Jessica Hall, Nicholas S Hengl and 11 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of public health, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02707991 (Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection), which is not on this map. Cited by 52 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02707991 nacompletednot on this mapstarted 2016, after this paper: background citation

Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection: A Randomized Controlled Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2016 to 2018Enrolled68ConditionsHIV, Hepatitis C, ChronicArmsNurse Case Management
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Review
  18. Article
  19. Article
  20. MTrials · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Carmen L MassonCarmen L. Masson, Kevin L. Delucchi, Jennifer Hettema, Nicole Pepper, Jessica Hall, Nicholas S. Hengl, Michael S. Shopshire, Jennifer K. Manuel, Bradley Shapiro, and James L. Sorensen are with the Department of Psychiatry, Mandana Khalili is with the Department of Medicine, and Hali Hammer is with the Department of Family and Community Medicine, University of California, San Francisco. Courtney McKnight, Albert Min, Ashly E. Jordan, Christopher Young, Lara Coffin, Randy M. Seewald, Henry C. Bodenheimer, Jr, Don C. Des Jarlais, and David C. Perlman are with the Beth Israel Medical Center, New York, NY.
Kevin L Delucchi
Courtney McKnight
Jennifer Hettema
Mandana Khalili
Albert Min
Ashly E Jordan
Nicole Pepper
Jessica Hall
Nicholas S Hengl
Christopher Young
Michael S Shopshire
Jennifer K Manuel
Lara Coffin
Hali Hammer
Bradley Shapiro
Randy M Seewald
Henry C Bodenheimer
James L Sorensen
Don C Des Jarlais
David C Perlman

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MEYERHOFF, DIETER J · 1994 to 2014
$28.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Hepatitis Care Coordination in Methadone TreatmentR01DA020841 · NIDA · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI PERLMAN, DAVID C · 2006 to 2010
$1.7M
Hepatitis Care Coordination in Methadone TreatmentR01DA020781 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MASSON, CARMEN L · 2006 to 2010
$1.7M
NIDA NIH HHS P30 DA011041NIDA NIH HHS P30DA 011041NIDA NIH HHS P50 DA009253NIDA NIH HHS P50DA009253NIDA NIH HHS R01 DA020781NIDA NIH HHS R01DA020781NIDA NIH HHS R01 DA020841NIDA NIH HHS R01DA020841NIDA NIH HHS T32 DA007250NIDA NIH HHS U10 DA015815NIDA NIH HHS U10DA015815NIDA NIH HHS UG1 DA015815NIDDK NIH HHS P30 DK026743NIMHD NIH HHS L60 MD003097
6 · The paper itself

Abstract

objectivesWe evaluated the efficacy of a hepatitis care coordination intervention to improve linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical evaluation of hepatitis C virus (HCV) infection among methadone maintenance patients.

methodsWe conducted a randomized controlled trial of 489 participants from methadone maintenance treatment programs in San Francisco, California, and New York City from February 2008 through June 2011. We randomized participants to a control arm (n = 245) and an intervention arm (n = 244), which included on-site screening, motivational-enhanced education and counseling, on-site vaccination, and case management services.

resultsCompared with the control group, intervention group participants were significantly more likely (odds ratio [OR] = 41.8; 95% confidence interval [CI] = 19.4, 90.0) to receive their first vaccine dose within 30 days and to receive an HCV evaluation within 6 months (OR = 4.10; 95% CI = 2.35, 7.17). A combined intervention adherence outcome that measured adherence to HAV-HBV vaccination, HCV evaluation, or both strongly favored the intervention group (OR = 8.70; 95% CI = 5.56, 13.61).

conclusionsHepatitis care coordination was efficacious in increasing adherence to HAV-HBV vaccination and HCV clinical evaluation among methadone patients.

Indexed as

Opiate Substitution TreatmentVaccinationAdultConfidence IntervalsFemaleHepatitis AHepatitis BHumansMaleMethadoneMiddle AgedNew York CityOutcome Assessment, Health CarePatient ComplianceSan FranciscoMethadone

Identifiers

PMID23947319
PMCPMC3853128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.